ANTI CARIOGENIC (Protecting From Tooth Decay)
April 30, 2022HSP70, THE ANTI-AGING PROTEIN
May 10, 2022- Regulation of inflammatory responses by natural anticoagulants
- natural anticoagulants and the liver
- Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
- natural anticoagulants, aging, and thromboembolism
- natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies
- Changes in the natural anticoagulants following bone marrow transplantation.
- The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients
- Deficiencies of natural anticoagulants, protein C, protein S, and antithrombin
- The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S
- natural anticoagulants: A missing link in mild to moderate bleeding tendencies
- Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants
- The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis.
- natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation
- Predictors of stroke outcome: the role of hemorheology, natural anticoagulants, and serum albumin
- Prognostic significance of D-dimer, natural anticoagulants and routine coagulation parameters in acute pancreatitis
- Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients …
- 5 The natural anticoagulants
- Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria
- Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial …
- … , protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on natural anticoagulants Study I Group
- natural anticoagulants can be useful predictors of severity in chronic liver disease
- natural anticoagulants (antithrombin III, protein C, and protein S) in patients with mild to moderate ischemic stroke
- natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid …
- The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus …
- Differential kinetics of coagulation factors and natural anticoagulants in patients with liver cirrhosis: potential clinical implications
- Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis.
- Coagulopathy of childhood nephrotic syndrome–a reappraisal of the role of natural anticoagulants and fibrinolysis
- Do age and anticoagulants affect the naturalhistory of acute subdural hematomas?
- Interactions between naturalhealth products and oral anticoagulants: spontaneous reports in the Italian Surveillance System of naturalHealth Products
- Origin of the gender differences of the naturalresistance to antivitamin K anticoagulants in rats
- Determinants of elevated levels of natural anticoagulants in healthy subjects
- Characterization of the coagulation system in healthy dolphins: the coagulation factors, natural anticoagulants, and fibrinolytic products
- VTE recurrence in patients with inherited deficiencies of natural anticoagulants
- Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins
- natural anticoagulants and their pathways
- Deficiencies of the natural anticoagulants–novel clinical laboratory aspects of thrombophilia testing
- Sulfated polysaccharide anticoagulants suppress naturalkiller cell activity in vitro
- Heparinase: II. Distribution of enzyme in various tissues and its action on naturalheparins and certain synthetic anticoagulants
- … disease in pediatric patients after hematopoietic stem cell transplantation: relevance of activated coagulation and fibrinolysis markers and natural anticoagulants
- natural anticoagulants in disseminated intravascular coagulation and sepsis
- Normal levels of the natural anticoagulants (proteins C & S and antithrombin III) and the fibrinolytic factors (tPA and PAI) in Arab children
- The level of natural anticoagulants in transfusion dependent thalassemia patients in Kelantan, Northeastern Malaysia
- The effect of delayed analysis or freeze-thawing on the measurement of natural anticoagulants, resistance to activated protein C and markers of activation of the …
- natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis
- ST-elevation myocardial infarction, pulmonary embolism, and cerebral ischemic stroke in a patient with critically low levels of natural anticoagulants
- Principal coagulation factors and natural anticoagulants in the armadillo Chaetophractus villosus (Mammalia, Xenarthra, Dasypodidae)
- Recombinant natural anticoagulants: a review.
- The evaluation of natural anticoagulants in systemic lupus erythematosus in children
- Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD–A longitudinal study
- Cerebral infarctions in young patients related to deficiency of natural anticoagulants. Protein C and protein S
- Deficiency of natural anticoagulants: how should we manage cardiovascular prevention?
- A survey of the clinical course and management of Japanese patients deficient in natural anticoagulants
- Genetic variation and natural anticoagulants
- Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis
- Anticuagulants: An overview of naturaland Synthetic Therapeutic anticoagulants
- Stability of prothrombin times in sheep dosed with naturaland synthetic anticoagulants
- naturalregulatory anticoagulants proteins among Sudanese patients with dengue virus infection
- Comparison of plasma levels of natural anticoagulants (protein C and protein S) among Jordanian smokers and non-smokers
- Alteration of some natural anticoagulants in dogs with chronic renal failure
- The interactions among B2-glycoprotein I, natural anticoagulants, and complement: significance for the antiphospholipid syndrome
- Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins.
- Levels of natural anticoagulants Protein C, Protein S and Antithrombin III in Patients with Solid Malignancies
- Deficiency of natural anticoagulants
- Predictive role of natural anticoagulants in Prognosis of Chronic Liver Disease in Pediatric Age Group
- PB2232 THE natural anticoagulants IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
- natural anticoagulants in sepsis—Too much of a good thing?
- natural anticoagulants deficiencies and transient ischemic attacks
- CHANGES IN THE LEVEL OF natural anticoagulants BLOOD PRETERM POSTNATAL.
- Experimental and clinical research on the interaction between inflammation and coagulation and its control by natural anticoagulants
- Coagulation factors and natural anticoagulants in polycythemia vera patients, relation with JAK2V617F mutation load
- Genetic thrombophilia and natural anticoagulants: importance of polymorphisms within and outside the genes
- Levels of natural anticoagulants, antithrombin III and protein C in diabetic vascular disease
- Effects of living at 300 meters below sea level on coagulation and natural anticoagulants.
- natural anticoagulants protein c and protein s in acute ischemic stroke in young adults
- An evaluation of natural anticoagulants and coagulation factors in patients with congenital disorders of glycosylation type I
- Inhibition of Pulmonary Coagulopathy by Nebulized natural anticoagulants during Streptococcus Pneumoniae Pneumonia in Rats
- natural anticoagulants and activated protein C resistance in patients with antiphospholipid antibodies (aPL) and in patients with pirmary venous thrombosis without …
- Preliminary Characterization of Occipodins, naturalProduct anticoagulants from Hematophagous Marine Parasites, Isopod Elthusa vulgaris and Copepod …
- Epoxidation of some skin-photosensitizes and anticoagulants of naturalcoumarin and furocoumarins as potential alkylating agents of DNA
- … open abdomen: an analysis of physiologic subgroups. The anticoagulated trauma patient: the Ontario experience in the era of direct oral anticoagulants. The effect of …
- naturalanticoagulant mechanisms.
- The regulation of naturalanticoagulant pathways
- A pharmacological review of dicoumarol: An old naturalanticoagulant agent
- New mechanisms for vascular control of inflammation mediated by naturalanticoagulant proteins
- Biochemistry of heparin antithrombin interactions, and the physiologic role of this naturalanticoagulant mechanism
- Profile of naturalanticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
- Beta2‐glycoprotein I in thrombosis: evidence for a role as a naturalanticoagulant
- Interaction between interleukin-6 and the naturalanticoagulant system in acute stroke
- Genome wide association study for plasma levels of naturalanticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project
- Deficiency of naturalanticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?
- Contribution of naturalanticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients
- Modulation of monocyte function by activated protein C, a naturalanticoagulant
- The role of naturalanticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis
- naturalanticoagulant pathways in normal and transplanted human hearts.
- … (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a naturalanticoagulant
- naturalanticoagulant protein levels in Turkish patients with inflammatory bowel disease
- Studies of naturalanticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant
- naturalanticoagulant inhibitors: activated Protein C
- Activated protein C, a naturalanticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation
- Antithrombin III in fresh and cultured human endothelial cells: a naturalanticoagulant from the vascular endothelium
- Age-specific onset and distribution of the naturalanticoagulant deficiency in pediatric thromboembolism
- Colloid transfusion, naturalanticoagulant depletion, and symmetric peripheral gangrene
- Targeting protease nexin-1, a naturalanticoagulant serpin, to control bleeding and improve hemostasis in hemophilia
- naturalanticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
- Increased risk of venous thrombosis in carriers of naturalanticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia …
- Analysis of inherited thrombophilic mutations and naturalanticoagulant deficiency in patients with idiopathic portal hypertension
- Alterations in naturalanticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients.
- Targeted gene disruption of naturalanticoagulant proteins in mice
- The endothelial heparan sulfate-antithrombin III naturalanticoagulant pathway in normal and transplanted human kidneys.
- Anticoagulant drugs increase naturalkiller cell activity in lung cancer
- naturalanticoagulant deficiencies in Thais: A population-based study
- Anticoagulant and antiprotease profiles of a novel naturalheparinomimetic mannopentaose phosphate sulfate (PI-88)
- naturalanticoagulant and fibrinolytic pathways in renal allograft failure.
- The naturalanticoagulant protein S is decreased in male smokers
- Uncovering the genetic background of naturalanticoagulant deficiencies: time to look behind the scenes
- Chemically sulfated naturalgalactomannans with specific antiviral and anticoagulant activities
- naturalanticoagulant proteins in the regulation of autoimmunity: potential role of protein S
- A review on anticoagulant/antithrombotic activity of naturalplants used in traditional medicine
- Structural features and anticoagulant activities of a novel naturallow molecular weight heparin from the shrimp Penaeus brasiliensis
- Association of the urine homocysteine/creatinine ratio to proinflammatory cytokine, naturalanticoagulant, and nitric oxide levels in cerebrovascular disease
- Effect of pulmonary tuberculosis on naturalanticoagulant activity in therapy-naïve Ghanaian adults; a case-control study
- naturalanticoagulant system in children with beta-thalassemia major
- … a new liquid chromatography-tandem mass spectrometry ion-trap technique for the simultaneous determination of thirteen anticoagulant rodenticides, drugs, or natural…
- … structural studies of two naturalisoforms of ammodytoxin, phospholipases A2 from Vipera ammodytes ammodytes which differ in neurotoxicity and anticoagulant …
- Type II protein C deficiency: identification and molecular modelling of two naturalmutants with low anticoagulant and normal amidolytic activity.
- Cerebral microbleeds in murine amyloid angiopathy: naturalcourse and anticoagulant effects
- Effects of anticoagulant, serum, and temperature on the naturalkiller activity of human peripheral blood mononuclear cells stored overnight
- Anticoagulant activity of a naturalprotein purified from Hypomesus olidus
- Anticoagulant activity screening of an in-house database of naturalcompounds for discovering novel selective factor Xa inhibitors; a combined in silico and in vitro …
- Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a naturalmixture of glycosaminoglycans
- Bioactive naturalCompounds with Antiplatelet and Anticoagulant Activity and Their Potential Role in the Treatment of Thrombotic Disorders
- Purification of Protein C, a naturalAnticoagulant, from Human Plasma by Affinity Chromatography with Convanavalin A
- naturalinhibitors of blood coagulation and fibrinolysis in patients with lupus anticoagulant.
- Pulmonary hypertension in adult Egyptian patients with b-thalassemia major: correlation with naturalanticoagulant levels
- Functional characterization of twelve naturalPROS1 mutations associated with anticoagulant protein S deficiency
- Activity levels of naturalanticoagulant proteins in childhood acute lymphoblastic leukemia: relation to thromboembolic complications and treatment
- Impact of sustained virus elimination on naturalanticoagulant activity in patients with chronic viral hepatitis C
- Membrane binding and anticoagulant properties of protein S naturalvariants
- Molecular modelling, 3D-QSAR, and drug docking studies on the role of naturalanticoagulant compounds in antithrombotic therapy
- Analysis of levels of naturalanticoagulant proteins and activated protein C resistance in venous thromboembolism patients referred to Iranian Blood …
- Congenital deficiencies of naturalanticoagulant systems responsible for recurrent thromboembolism
- Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, naturalinhibitors and molecular markers of thrombosis.
- Impact of erythrocytapheresis on naturalanticoagulant levels in children with sickle cell disease: A pilot study
- IN VITRO AND IN VIVO ANTICOAGULANT ACTIVITY OF IMPERATA CYLINDRICA A NOVEL ANTICOAGULANT LEAD FROM naturalORIGIN.
- 3 The Heparan Sulfate-Antithrombin Pathway: A naturalAnticoagulant Mechanism of the Blood Vessel Wall
- Mechanisms of the antimetastatic effects of anticoagulant drugs: dependence on naturalkiller (NK) cell activity
- Haemorheological, naturalAnticoagulant and Homocysteine Profiles in Coeliac Disease: a Case-control Study
- Effects of acrolein, a naturaloccurring aldehyde, on the anticoagulant serpin antithrombin
- Effects of pulse-therapy on naturalanticoagulant system of the endothelium in nonspecific aortoarteritis
- A STUDY OF naturalOCCURRING ANTICOAGULANT AND ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH HISTORY OF THROMBOSIS IN TEHRAN
- THE POTENTIAL OF NYAMPLUNG LEAF EXTACT AS A naturalANTICOAGULANT
- Extraction of Sulphated Polysaccharides (SPs) from Different Species of Marine Macroalgae and Studying their Role as naturalAnticoagulant
- Pathogenetic Substantiation of the Usability of the naturalAnticoagulant Sulodexide in a Combine Treatment of Pregnant Women with Premature Delivery
- The anticoagulant, hepatic lipase-releasing and lipoprotein lipase-releasing activities of several naturaland chemically modified heparins differ
- naturalanticoagulant and antifibrinolysis in patients with chronic renal failure with and without hemodialysis
- Haemorheological, naturalAnticoagulant and Homocysteine Profiles in Coeliac Disease: A Case-control Study
- naturalANTICOAGULANT-PROTEIN S DEFICIENCY AND PREGNANCY OUTCOME-A RARE CASE REPORT
- Zinc Binds and Regulates the Activity of the naturalAnticoagulant Protein Z
- Anticoagulant and Antiprotease Profiles of a Novel naturalHeparinomimetic Mannopentaose Phosphate Sulfate (PI-88)
- Marine Sulfated Polysaccharides with Unusual Anticoagulant Action through an Additional Unrelated naturalInhibitors Mechanism
- Hereditary deficiency of all vitamin K‐dependent procoagulants and anticoagulants
- Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus.
- < The> natural anticoagulants
- The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial.
- Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
- Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.
- Prothrombotic states in young people with idiopathic stroke. A prospective study.
- Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.
- Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism.
- Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study
- High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.
- Postoperative changes in coagulant and anticoagulant factors following abdominal aortic surgery
- High levels of factor VIII and venous thrombosis
- Coagulation factors in nephrotic syndrome
- Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes
- Risk factors for thromboembolism: pathophysiology and detection
- Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection
- Thrombophilia in pregnancy
- Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy
- The Significance of TFPI in Clotting Assays–Gomparison and Combination with other anticoagulants
- Nature’s anticoagulants: controlling the clotting cascade
- Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver
- Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?
- Arg506–Gln mutation in factor V and risk of thrombosis during pregnancy
- Epidemiology of coagulation disorders
- Familial coagulation-inhibiting and fibrinolytic protein deficiencies in juvenile transient ischaemic attacks.
- Congenital deficiency of histidine-rich glycoprotein: failure to identify abnormalities in routine laboratory assays of hemostatic function, immunologic function, and trace …
- Factors in xenograft rejection
- Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing …
- Risk of thromboembolic complications in patients with inflammatory bowel disease
- Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate.
- Factor Vila and other haemostatic variables following bone marrow transplantation
- Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden
- Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia
- Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C
- Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin gene
- Protein C, isolation and potential use in prevention of thrombosis.
- Disseminated intravascular coagulation findings in 100 patients.
- The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial
- Changes in the plasma levels of proteins C and S in young women on low-dose oestrogen oral contraceptives.
- Thrombosis promoting changes in chronic liver diseases.
- Markers of thrombin and plasmin generation in patients with inherited thrombophilia.
- Protein S deficiency associated to anti-protein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol
- Relationship between vitamin K dependent coagulation factors and anticoagulants (protein C and protein S) in neonatal vitamin K deficiency.
- Significant elevation of protein C and protein S levels in thrombotic disorders by low dose danazol.
- Antiphospholipid antibody and antiphospholipid antibody syndrome.
- A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis
- Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism
- Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with …
- Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid
- Changes of hemostatic factors in patients with hemoglobinopathies.
- The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss
- Overtight nappy precipitating thrombosis in antithrombin III deficiency.
- EFFECT OF PORCINE ENDOTHELIAL TISSUE FACTOR PATHWAY INHIBITOR ON HUMAN COAGULATION FACTORS1
- Alpha2-macroglobulin levels are high in adult patients with congenital antithrombin deficiency
- Activated protein C and antithrombin-III activity during arterial thrombolysis with recombinant tissue-type plasminogen activator in rabbits.
- Protein C deficiency: summary of the 1995 database update
- Effect of thymalin on blood coagulation and fibrinolysis
- Acute fibrinolysis following craniotomy and removal of metastatic tumor of the cerebellum: case report
- Hypercoagulable states in arterial thromboembolism
- Treatment of deep vein thrombosis using temporary vena caval filters after allogeneic bone marrow transplantation
- Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation
- Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
- Hemostasis activation in patients with liver cirrhosis
- The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis
- Hereditary protein S deficiency and familial thrombosis. A review with description of a Danish family with protein S deficiency
- Effect of intravenous infusions of thrombin and heterogenous blood on lymph coagulability
- Protein C, protein S and heparin cofactor II–their significance as the regulatory factors in the blood coagulation cascade
- A search for autoantibodies to thrombomodulin in patients with documented thrombosis
- Venous thrombosis: antithrombin III deficiency.
- Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever
- AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state
- Naturally occurring anticoagulants and bone marrow transplantation
- Thrombophilia: some recent advances in understanding.
- Hypercoagulability syndrome due to heparin co-factor deficiency
- Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults.
- Laboratory test utilization in the diagnosis of hypercoagulability
- Correlation of haemostatic variables and structural changes of major arteries of the head in ischemic stroke patients
- Effects of recombinant human erythropoietin [rHuEPo] on haemostasis in patients maintained on chronic hemodialysis
- Role of the parasympathetic division of the autonomic nervous system in regulating blood coagulation and fibrinolysis following intravenous injection of thrombin
- A Case of Congenital Vitamin K Dependent Coaguation Factor Defeciency
- Hemostatic Abnormalities Related to Bone Marrow Transplantation
- New agents for the treatment of thrombosis
- EXPRESSION OF HUMAN THROMBOMODULIN COFACTOR ACTIVITY IN PORCINE AORTIC ENDOTHELIAL CELLS.
- PCR screening method to detect factor v leiden mutation in tia and stroke
- Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation
- Is inherited thrombophilia a risk factor for arterial stroke?
- Inherited fibrinogen abnormality causing thrombophilia
- Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis
- Infrequency of stroke caused by specific coagulation disorders
- Organization of a Randomized Clinical Trial for the Prevention of Recurrent Thrombosis in the Antiphospholipid Syndrome: the WAPS Project (Warfarin in …
- Fortnightly review: Disseminated intravascular coagulation: Diagnosis and treatment
- Cerebral infarction and familial protein S deficiency.
- Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: a comparative crossover study
- Budd‐chiari syndrome associated with factor V leiden mutation: A report of 6 patients
- FV-ARG-506-GLN-mutation-associated resistance to activated protein C in ischemic stroke
- Antiphospholipid syndrome patients’ monocytes are “primed” to express tissue factor
- Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of …
- Disseminated intravascular coagulation (DIC)
- Protein S deficiency and factor V Leiden gene in pregnancy
- L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation
- The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the …
- Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria
- The investigation of patients with retinal vascular occlusion
- Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans
- Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement
- The therapeutic potential of novel anticoagulants
- Isolated familial plasminogen deficiency may not be a risk factor for thrombosis
- preparation: pre-analytical variation
- The Biologic Impact of Hereditary Defects that Cause Thrombosis
- Anticoagulation in patients with acute renal failure treated with continuous renal replacement therapies
- EXPRESSION OF HUMAN THROMBOMODULIN COFACTOR ACTIVITY IN PORCINE ENDOTHELIAL CELLS1, 2
- Cerebral Infarction in PeopleUnder 40 Years I
- Inhibition of endothelial cell thromboresistance by homocysteine
- Progressive intracranial occlusive disease associated with deficiency of protein S. Report of two cases.
- Thrombophilia testing: what do we think the tests mean and what should we do with the results?
- Blood coagulation and its alterations in hemorrhagic and thrombotic disorders.
- Obstetric Complications: Consumption Coagulopathy
- Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients
- Factor V Leiden is associated with repeated and recurrent unexplained fetal losses
- Changes in the plasma levels of vitamin K‐dependent proteins C and S and of C4b‐binding protein during pregnancy and oral contraception
- The molting cycle of the spiny lobster, Panulirus argus Latreille. III. Physiological changes which occur in the blood and urine during the normal molting cycle
- Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of …
- A Rapid and reliable PCR based method for detecting the blood coagulation Factor V Leiden mutation
- Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant
- Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link
- Recombinant tissue plasminogen activator (rt‐PA) for veno‐occlusive liver disease in pediatric autologous bone marrow transplant patients
- Hypercoagulable abnormalities and postoperative failure of arterial reconstruction
- Prevalence of anti–protein S antibodies in patients with systemic lupus erythematosus
- Protein C and S response to danacrine in end-stage renal disease
- Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment
- Diffuse arterial thrombosis in a young man with elevated lipoprotein (a) and minimal atherosclerosis
- Relationship between maternal antithrombin III and protein C/protein S levels before, during and after delivery
- Prothrombotic risk factors and acute kidney transplant rejection
- Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation
- The diagnosis and clinical management of thrombophilia
- Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study
- Thromboelastography identifies sex-related differences in coagulation
- Cardiovascular materials
- In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia major
- Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
- Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke
- The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit
- Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin (∗)
- The thrombophilic state induced by therapeutic agents in the cancer patient
- The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population
- Hypercoagulable states: molecular genetics to clinical practice
- Inherited thrombophilia and pregnancy
- Cerebral venous sinus thrombosis associated with hepatic cirrhosis
- Prothrombotic states associated with retinal venous occlusion in young adults
- An abnormal plasma distribution of protein S occurs in functional protein S deficiency
- Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders
- Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment
- Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke …
- Hypercoagulable states in patients with leg ischaemia
- Multiple organ dysfunction syndrome in bone marrow transplantation
- Early hemostatic alterations following bone marrow transplantation: a prospective study
- Evaluation of the hypercoagulable state: whom to screen, how to test and treat
- Thrombin inhibition in discordant xenograft rejection
- Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L …
- Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters
- THROMBOSIS IN CHURG—STRAUSS SYNDROME. BEYOND VASCULITIS?
- Hereditary protein C deficiency and portal-vein thrombosis.
- Cancer, thrombosis, and anticoagulants
- Why do patients with antiphospholipid antibody clot?
- Does thrombophilia play an aetiological role in Legg-Calvé-Perthes disease?
- Age-related differences in outcome and severity of DIC in children with septic shock and purpura
- Post-chemotherapy Sweet’s syndrome in three patients with AML
- Coagulation abnormalities in sepsis: relation with inflammatory responses
- Physiologic changes in coagulation and fibrinolysis during normal pregnancy
- Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus
- Investigations for thrombotic tendencies
- Thrombophilia: a genetic predisposition to thrombosis.
- High level of protein C and protein S in nephrotic syndrome
- Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis
- Presence of serum antibodies to coagulation protein C in patients with systemic lupus erythematosus is not associated with antigenic or functional protein C …
- Arterial thrombosis in nephrotic syndrome due to minimal change glomerulonephritis
- Prevalence of protein C deficiency in the healthy population
- Neurology and the blood: haematological abnormalities in ischaemic stroke
- Mesenteric venous thrombosis: a case report
- Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared to CAPD
- Detection of the prethrombotic state due to procoagulant imbalance
- Effect of acetylcholine and atropine on the secretion of blood clotting compounds into the blood stream by the kidneys
- Efficacy of danazol in a patient with congenital protein s deficiency: Paradoxical evidence for decreased platelet activation with increased thrombin generation
- Veno‐occlusive disease of the liver after hemopoietic cell transplantation
- Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study
- Lower extremity arterial occlusions in young patients with Crohn’s colitis and premature atherosclerosis: report of six cases.
- Influence of demographic factors on antithrombin III activity in a healthy population
- Warfarin-induced skin necrosis
- Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see …
- Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism
- Pathogenesis of Thrombotic Complications of Haematological Malignancies
- Laboratory markers of coagulation activation
- A hirudin catching ELISA for quantitating the anticoagulant in biological fluids
- Basic analytical parameters as the predictive factors for 30‐day case fatality rate in stroke
- The role of platelets in the coagulopathy of heatstroke a study of platelet aggregation in heatstroke patients during the Makkah pilgrimage (Haj) to
- Hydroxylation of styrene-diene triblock copolymers in solution and on the surface
- Reversal of thrombocytopenia following oral anticoagulation in two patients with primary antiphospholipid syndrome
- Sustained bleeding after a leech bite in the apparent absence of hirudin
- Antiphospholipid antibodies, prethrombotic states, and stroke.
- Protein C pathway, antiphospholipid antibodies and thrombosis
- Antiphospholipid antibodies, haemostatic variables and thrombosis–a survey of 144 patients
- Lower extremity amputations in adults less than forty years of age: an underestimated risk from premature atherosclerosis
- High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria
- Strokes in Thai children: etiology and outcome.
- Stroke in relapsing thrombotic thrombocytopenic purpura.
- Disseminated intravascular coagulation
- Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation
- Hypercoagulability and the management of anticoagulant therapy in surgical patients: review and recommendations
- Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome?
- Effects of annexin V on the activity of the anticoagulant proteins C and S
- Contraceptive choices in women with coagulation disorders
- Frequency of protein S deficiency in general Japanese population
- 7 Antiphospholipid antibodies and thrombosis
- Basic, laboratory and clinical aspects of thromboembolic diseases
- Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors
- Is there a need for antithrombin III substitution early after burn injury?
- Enhancement of protein S anticoagulant function by β2-glycoprotein I, a major target antigen of antiphospholipid antibodies
- Acidosis induced disseminated intravascular microthrombosis and its dissolution by streptokinase
- A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?
- Efficacy and safety of weight-adapted nadroparin calcium vs. heparin sodium in prevention of clinically evident thromboembolic complications in 1,190 general …
- Hemostasis in dentistry, with special reference to hemocoagulation: I. The basic theory of hemostasis
- Immunology: Antiphospholipid antibodies and β2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach
- Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs
- The antiphospholipid/cofactor syndromes: a primary variant with antibodies to β2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays
- Association of osteonecrosis in systemic lupus erythematosus with abnormalities of fibrinolysis
- Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factors
- Recent advances in understanding clotting and evaluating patients with recurrent thrombosis
- An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans–associated meningococcemia
- Preparation for regional anaesthesia induces changes in thrombelastography
- The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?
- Thrombotic risk during pregnancy and puerperium in women with APC-resistance–effective subcutaneous heparin prophylaxis in a pregnant patient
- Superior sagittal sinus and inferior vena cava thrombosis with acute Budd-Chiari syndrome.
- Coagulation and anticoagulation systems in newborns–correlation with their mothers at delivery
- Cells and the activation of factor VII
- Diagnosis and management of pulmonary embolism in pregnancy
- Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty
- Passive smoking adversely affects the haemostasis/fibrinolytic parameters in healthy non-smoker offspring of healthy smokers
- Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis
- Enhancement of plasminogen binding and fibrinolysis by chloropeptin I
- Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies-a crucial role for acquired free protein S deficiency
- Is testing for inherited coagulation inhibitor deficiencies in young stroke patients worthwhile?
- Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndrome
- Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud’s phenomenon and thrombosis
- Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
- The antiphospholipid syndrome
- Oral anticoagulation in the community
- A hypercoagulable state in activated protein C resistant patients with ischemic stroke
- Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome
- Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?
- Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts
- Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy?
- Blood collection and sample preparation: pre-analytical variation
- Recurrent renal vein thrombosis and renal failure associated with antithrombin-III deficiency
- The nephrotic syndrome and its complications
- Risk factors for venous thromboembolism in pregnancy
- Disseminated intravascular coagulation in elective primary total hip replacement
- Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion
- Clotting for the clinician: an overview of thrombosis and antithrombotic therapy
- Placental pathology in antiphospholipid antibody syndrome
- Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis
- Arterial thrombosis associated with immune thrombocytopenia: presence of a platelet aggregating IgG synergistic with thrombin and adrenalin
- Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment
- Aprotinin in deep hypothermic circulatory arrest
- Endothelial cell injury in cardiovascular surgery
- Arterial thrombosis of the arm in infant of diabetic mother
- Circulating anticoagulants: physiologic and pathophysiologic
- Hypercoagulable state and graft rejection—is there a link?
- The role of heparin in intrinsic blood coagulation
- Haematological manifestations of systemic lupus erythematosus
- Hepatic veno-occlusive disease after bone marrow transplant
- Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism
- Patient management of pulmonary embolism
- Changes in plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) by the interferon treatment for chronic hepatitis C
- Study of the Pharmacological Effect of the Bile Salt, Sodium Scymnol Sulfate, from Rhizoprionodon acutus. II.: Prophylactic Effect of Scymnol on Lesion Development …
- Low‐dose warfarin decreases coagulability without affecting prothrombin complex activity
- A comparative study of the clotting power of the blood and lymph
- Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
- Free protein S deficiency: a possible association with cerebrovascular occlusion.
- Effect of tamoxifen on measurements of hemostasis in healthy women
- Clinical Associations of Antibodies to Phospholipids and/or
- Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis
- Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease
- Interleukin-1 in haemophilic arthritis
- Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiency
- Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden
- Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency
- Effect of acupuncture on monoamines and adenosine triphosphatase activity in lateral hypothaiamic area of obese rats
- Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides
- Cranial sinus thrombosis and preeclampsia.
- The effect of n-3 fatty acids on blood coagulation
- Response to activated protein C upon storage of whole blood and plasma
- Vascular-bed–specific hemostasis and hypercoagulable states
- Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission
- Disseminated Intravascular Coagulation in Individuals with Cancer
- Prevalence of mutated factor V ARG506 to GLN in Italians
- Polyion sensors as liquid junction‐free reference electrodes
- Cerebral venous thrombosis in the nephrotic syndrome
- Relation of the changes in hemorheologic indices and the site and size of cerebral infarction
- Effect of hemodialysis on protein C, protein S, and antithrombin III levels
- Venous surgery in patients with congenital antithrombin III deficiency
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile
- 35 LABORATORY INVESTIGATION OF HAEMOSTASIS
- Effect of subcutaneous administration of recombinant human erythropoietin on plasma protein C, protein S, and antithrombin III levels in patients on continuous …
- Functional activity of protein C in liver cirrhosis and acute viral hepatitis on the Ivory Coast.
- Transcranial Doppler patterns in patients with anticardiolipin antibodies
- Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature
- The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
- Analysis of blood coagulation in the zebrafish
- Sagittal sinus thrombosis associated with transient free protein S deficiency after L-asparaginase treatment: case report and review of the literature
- Thromboembolic disease in pregnancy
- Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis
- The antiphospholipid-protein syndrome
- Overview of the Hypercoagulable States
- The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow …
- The syndrome of hepatic veno-occlusive disease after marrow transplantation
- Department of Dermatology
- Transient correction of partial congenital factor V deficiency in nephrotic syndrome
- Anticuerpos antifosfolipido: Valoracion de los sistemas de la hemostasia.
- Classification of Pressure Ulcers-Reply
- Venous thromboembolism and cancer: a two-way clinical association
- Antithrombotics/serine proteases
- Pulmonary embolism in a patient with coagulopathy from end-stage liver disease
- The prothrombin response to the parenteral administration of large doses of vitamin K in subjects with normal liver function and in cases of liver disease: a …
- Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden)
- Treatment of patients with antiphospholipid antibodies during pregnancy
- Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S
- A comparison of postoperative thrombotic potential following abdominal aortic surgery, carotid endarterectomy, and femoro-popliteal bypass
- Tissue factor pathway inhibitor and the revised theory of coagulation
- Computer-aided design of thrombin inhibitors
- Current concepts of anticoagulant therapy in pregnancy
- Resolution of Budd‐Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria
- Evaluation of the haemostatic system during ketoacidotic deterioration of diabetes mellitus
- The expression of coagulation factors during murine development
- Fundamental research in molecular biology: relevance to medicine
- How to detect activated coagulation
- Splenomegaly, hypersplenism and coagulation abnormalities in liver disease
- Thrombosis and hemostasis in renal disease
- Vascular homeostasis, adhesion molecules, and macrovascular disease in non‐insulin‐dependent diabetes mellitus
- Clinical trials for the antiphospholipid syndrome
- Protein S deficiency in lupus erythematosus secondary to hereditary angio‐oedema
- Arg sup 506-Gln Mutation in Factor V and Risk of Thrombosis During Pregnancy
- The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis
- Early prediction of stroke severity: role of the erythrocyte sedimentation rate
- The G20210A polymorphism in the 3′-untranslated region of the prothrombin gene in Mexican mestizo patients with primary antiphospholipid syndrome
- The effect of near‐normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulant proteins C and S in insulin‐dependent diabetic patients
- Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes
- The effect of epidural blockade on postoperative hypercoagulability following abdominal aortic bypass surgery
- Cerebral venous thrombosis in patients with nephrotic syndrome
- The control of thrombin generation in haemoglobinopathies and other haemolytic red cell disorders in children
- Catastrophic antiphospholipid syndrome
- Thrombophilia: how far should a clotter be investigated?
- Hypercoagulable states and lower limb ischemia in young adults
- Administration of autologous fetal membranes: effects on the coagulation in pregnant mini-pigs
- Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy
- The prediction of thromboembolism
- Ischemic stroke in Korean young adults
- A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
- Isolation and characterization of americanin, a specific inhibitor of thrombin, from the salivary glands of the lone star tickAmblyomma americanum (L.)
- Protein C deficiency and portal thrombosis in liver transplantation in children
- Platelets abolish the profibrinolytic effect of activated protein C
- An investigation of the role of antiphospholipid antibodies and [beta] 2 glycoprotein-I in the modulation of haemostatic reactions
- Management of thrombophilia in pregnancy
- Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis
- Deep cerebral venous thrombosis and hereditary tissue plasminogen activator (t-PA) deficiency
- Premature closure of foramen ovale and renal vein thrombosis in a stillborn twin homozygous for methylene tetrahydrofolate reductase gene polymorphism: A …
- Lupus anticoagulant in patients with peripheral vascular disease: a prospective study
- Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement
- The effect of n‐3 polyunsaturated fatty acids on lipids, haemostasis, neutrophil and monocyte chemotaxis in insulin‐dependent diabetes mellitus
- Early pathophysiology of osteonecrosis
- Abnormalities in the protein C anticoagulant pathway detected by a novel assay using human thrombomodulin
- Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human α‐thrombin
- Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli
- New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy
- Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy
- A new blood-clotting theory
- Antiphospholipid syndrome
- Increased Risk for Venous Thrombosis in Carriers of the Prothrombin G→A20210 Gene Variant
- Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying’Membrane Stress Syndrome’ …
- Acute coronary syndromes: unstable angina and non–Q-wave myocardial infarction
- Heparin, its chemistry, pharmacology and clinical use
- Acquired free protein S deficiency in children with steroid resistant nephrosis
- The role of thrombosis in severe pulmonary hypertension
- Analysing early liver dysfunction after bone marrow transplantation
- Rapid detection of anticardiolipin antibodies
- Warfarin-induced complete bilateral breast necrosis
- Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients
- Meconium and amniotic fluid embolism: effects on coagulation in pregnant mini-pigs
- Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings
- α-Thalassemia among pediatric Nb S homozygotes
- On the nature of hypercoagulability
- Absence of thrombosis in subjects with heterozygous protein C deficiency
- Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome
- Contents, Vol. 26, 1996
- Anticardiolipin and acquired protein S deficiency in early childhood
- Drug Treatment of Stroke in Patients with Antiphospholipid Antibodies
- Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases
- Protein C levels as a prognostic indicator of outcome in sepsis and related diseases
- Pregnancy outcome in women with antiphospholipid antibodies
- Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis
- Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients
- Recombinant Hirudin
- Effectiveness and safety of blood transfusion: have we lost the plot?
- Practical haemodialysis began with cellophane and heparin: the crucial role of William Thalhimer (1884–1961)
- THE SEQUENTIAL IN UTERO DEATH OF HETEROKARYOTIC MONOZYGOTIC TWINS. A CASE REPORT AND LITERATURE REVIEW
- anticoagulants in women
- Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study
- LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENO-OCCLUSIVE DISEASE OF THE LIVER IN BONE MARROW TRANSPLANTATION …
- Protein S deficiency occurs in the nephrotic syndrome
- Human genetic diseases of proteolysis
- Protein S and protein C anticoagulant activity in acute and chronic cardiac ischemic syndromes. Relationship to inflammation, complement activation and in vivo …
- Multicenter comparison of five functional and two immunological assays for protein C
- Prevalence of the prothrombin gene variant 20210 G→ A among patients with myocardial infarction
- Hypercoagulable states in patients with retinal venous occlusion
- Prothrombotic and antithrombotic factors are elevated in patients with type 1 diabetes complicated by microalbuminuria
- anticoagulants in pregnancy
- Protein S and C antigen levels in proteinuric patients: Dependence on type of glomerular pathology
- Cerebral venous thrombosis in patients with nephrotic syndrome
- Classification of pressure ulcers
- Cerebral venous thrombosis and procoagulant factors: a case study
- The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns
- Haemostatic factors in human peripheral afferent lymph
- The endothelium and thrombosis
- Primary thrombophilia in Mexico: a prospective study
- State-of-the-Art Review: Chemotherapy and Thrombosis in Gynecologic Malignancy
- The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S
- Hypercoaguable State Associated with a Deficiency of Protein C in a Thoroughbred Colt
- Fibrinolytic Abnormalities and Antiphospholipid Antibodies
- Lower extremity ischemia in adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease
- The Effect of n-3 Fatty Acids on Lipids and Haemostasis in Patients with Type lla and Type IV Hyperlipidaemia
- Thrombin signalling and protease-activated receptors
- α1-antitrypsin, an inhibitor for thrombin and plasmin
- Production of phospholipid antibodies in selected thrombophilic women differing in genotype at the 506 site of factor V
- Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation
- Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation
- Anticoagulation in pregnancy
- Endothelial cell injury in cardiovascular surgery: an overview
- Anticoagulation in
- Circulating levels of endothelial function are modulated by dietary monounsaturated fat
- Prothrombotic abnormalities in inflammatory bowel disease
- Significance of glomerular deposition of protein S in various glomerulopathies
- The kaleidoscope of autoimmunity
- Endothelial dysfunction in critically ill patients: the effect of haemofiltration
- Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion.
- Management of the Septic Patient in the Operating Room
- Stroke in childhood
- 2 Congenital thrombophilia
- Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus
- Problems with anticoagulation for continuous renal replacement therapies
- Low-dose oral contraceptive usage and coagulation
- Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options
- Plasma levels of D‐dimer and circulating endothelial adhesion molecules in veno‐occlusive disease of the liver following allogeneic bone marrow transplantation
- Cerbral venous thrombosis in ulcerative colitis and review of the literature
- Thromboembolic risks and complications in nephrotic children
- A familial hemorrhagic diathesis due to an antithrombin
- A missense mutation in γ-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors
- Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives
- Muscle infarction in diabetes: Clinical manifestations and course
- The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects
- Advances in antithrombotic drug therapy for coronary artery disease
- Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range
- Guidelines for the management of thrombophilia. Department of Haematology, The Royal London Hospital, Whitechapel, London, UK.
- An overview of thrombolytic agents
- An experimental investigation into the causes of disseminated intravascular coagulation in hemorrhagic shock
- Deep venous thrombosis and pulmonary embolism in pregnancy
- Hemostasis in malignancy
- The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors
- Turbulent Mass Transport and Flame Spreading Rates Within Turbulent Flames Confined in a Variable Area Duct
- Central venous catheters for hemodialysis: How to overcome the problems
- Prothrombotic abnormalities in children with venous thromboembolism
- Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus
- Broadsheet number 53: activated protein c resistance: diagnosis and clinical management
- Homocysteine, coagulation, platelet function, and thrombosis
- Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease
- Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation
- Dealing with Drug-Induced Thrombocytopenia: Case Commentary
- The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke
- Potentiation of the Action of Warfarin by Bezafibrate in Patients with the Nephrotic Syndrome
- Hypercoagulability in vascular surgery patients
- Young women with advanced aortoiliac occlusive disease: new insights
- Antithrombin: the principal inhibitor of thrombin
- The alterations of the activities of coagulation inhibitors and fibrinolytic factors in stored cord blood could affect the yield of progenitor cells during processing
- Coagulation for blood bankers
- Pathogenic role of antiprotein-phospholipid antibodies
- Mechanisms of hypercoagulation in malignancy and during chemotherapy
- Blood cardiolipin in haemodialysis patients. Its implication in the biological action of platelet-activating factor
- Thromboembolic complications of polycythemia: Polycythemia vera versus smokers’ polycythemia
- Arterial thrombosis in the nephrotic syndrome.
- Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment
- Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.
- Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis
- The changing epidemiology of asthma
- Hysterectomy techniques and their effect on the blood markers of thrombogenicity
- Sequential treatment of recurrent mesenteric desmoid tumor
- Serum antibodies to distinct epitopes of the tissue‐type plasminogen activator (t‐PA) in patients with systemic lupus erythematosus
- Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis
- Homocysteine and oxidized low density lipoprotein enhance platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic …
- Normal fetal growth in women with antiphospholipid syndrome treated with high‐dose intravenous immunoglobulin (IVIG)
- Lupus anticoagulant testing with optical end point automation
- Thromboembolism after hip and knee arthroplasty: diagnosis and treatment
- Coagulation changes in the neonatal period and in early infancy
- Prevalence of factor V Leiden in young adults with retinal vein occlusion
- The Subcutaneous Use of Heparin: A Summary of Observations
- Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells
- Vascular endothelium, haemostasis and thrombosis
- Stroke and antiphospholipid antibodies
- Antiphospholipid antibodies: lupus anticoagulant and anticardiolipin antibody
- Acute aortic thrombosis associated with spinal cord infarction in nephrotic syndrome
- Familial coexistence of primary antiphospholipid syndrome and factor VLeiden
- Clinical and biological aspects of juvenile thrombophilia
- Evaluation of Ischemic Stroke and Recurrent Ischemic Attack
- Oral contraceptives and blood coagulation: a critical review
- Topical diagnosis: prechiasmal visual pathways
- Variations in hemostatic parameters after near-maximum exercise and specific tests in athletes
- Venous thrombosis and women’s health: Identification of risk factors and long terms effects
- 3 Megakaryocytic cell lines
- Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome
- Management of Antepartum Fetal Death
- Coagulation studies and fistula blood flow during erythropoietin therapy in haemodialysis patients
- Fibrinolysis in patients with the 1691 G→ A mutation in factor V gene and history of deep vein thrombosis
- Thromboembolism in obstetrics
- Structure and function of endothelial cell integrins
- Thrombosis risk in the trauma patient: prevention and treatment
- Blood coagulation from the beginning until to-day
- Hypercoagulability following multiple trauma
- Effect of xuefu zhuyu decoction on the function of platelets and human umbilical vein endothelial cell
- Postpartum pyometra: a case report
- ACUTE CORONAR’Y SYNDROMES
- Strategies for the design of novel thrombolytic and antithrombolytic agents
- Antiphospholipid syndrome and the skin
- β2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis
- Venous thromboembolism
- Intravascular agglutination of the formed elements of blood
- Effect of plasma from patients with primary antiphospholipid syndrome on platelet function in a collagen rich perfusion system
- Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates
- Pathogenesis of and potential therapies for delayed xenograft rejection
- 11a Thrombosis and embolism
- Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?
- A sensitized clotting time
- Antiphospholipid antibodies and the antiphospholipid antibody syndrome
- Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells
- Hemostasis in renal disease: pathophysiology and management
- Modulation of hemostatic mechanisms in bacterial infectious diseases
- Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation
- Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients
- Deep vein thrombosis in pregnancy and the puerperium: a comprehensive review
- Protein C and protein S clinical perspectives
- CLINICO-PATHOLOGICAL EVALUATION OF PREGNANCY INDUCED HYPERTENSION
- PACU and ICU care: Evaluation and management of postoperative cardiovascular complications
- Protein C activity and antigen
- Prevalence of the C677T methylenetetra-hydrofolate reductase mutation in Thai patients with deep vein thrombosis
- Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy
- A Summary of Observations
- Regulation of blood coagulation
- Hereditary protein S deficiency in a large New Jersey kindred
- The prognostic value of the acute‐phase response in stroke recurrence
- Animal studies clearly indicate that dietary marine oils have antithrombotic effects, especially when they replace saturated fany acids in the diet. This chapter reviews …
- Fibromyalgia and interleukin-2 therapy for malignancy
- The syndrome of veno-occlusive disease after blood or marrow transplantation
- The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service
- Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation
- State-of the-Art Review: Prevention of Thrombosis in Gynecologic Malignancy
- Sex hormone binding globulins and atherosclerotic risk in systemic lupus
- Pharmacological actions of sulodexide
- Pulmonary embolism: diagnosis and treatment
- Analysis of hemostasis in the zebrafish
- Antiphospholipid Syndromes and the Nervous System Clinical Features, Mechanisms, and Treatment
- Pre-and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease-a preliminary study
- Studies on Thrombin Formation
- Deep venous thrombosis and pulmonary embolism
- Antithrombotic and thrombolytic therapy for coronary heart disease: consensus and controversy
- A review of tissue plasminogen activator in the treatment of veno‐occlusive liver disease after bone marrow transplantation
- Plasma levels of lipoprotein (a) are elevated in patients with the antiphospholipid antibody syndrome
- Endothelium-derived haemostatic factors and the antiphospholipid syndrome
- Physiology of blood coagulation
- Poly‐(2‐hydroxyethyl methacrylate) particles for preoprative endovascular occulusion of extensive angiodysplasias
- Intensive Treatment of the Patient with Hepatic Trauma
- Venocclusive disease of the liver after bone marrow transplantation: the role of hemostasis
- Newer strategies for the treatment of heparin‐induced thrombocytopenia
- Bleeding in Transplantation Surgery
- Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity
- Anticoagulant activity of sulfated polysaccharides isolated from Codium fragile
- Genetic markers: genes involved in thrombosis
- Interactions Between Malignancy and Coagulation
- The pathogenesis, diagnosis and treatment of strokes: a progress report
- Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestations
- Estimating true fractional calcium absorption
- The anticoagulant properties of a modified form of protein S
- Resistance to activated protein C and a novel factor V gene mutation
- Protein C in acute stroke.
- Mechanism of blood coagulation in normal and pathologic conditions
- Risk factors for stroke in young Indonesian women
- The retinoic acid and cAMP-dependent up-regulation of 3-O-sulfotransferase-1 leads to a dramatic augmentation of anticoagulantly active heparan sulfate …
- Combination oral contraceptives and cardiovascular disease
- Anti-phospholipid antibody syndrome: medical zebra: or, just the stripes
- Acute ischemic stroke: update on treatment and prevention
- Rheumatoid arthritis and connective tissue diseases
- Fibrinogen Bellingham: A γ‐chain R275C substitution and a β‐promoter polymorphism in a thrombotic member of an asymptomatic family
- Coagulation parameters in maternal and cord blood at delivery
- The physiological significance of phospholipase A (2) activity in the saliva of the lone star tick, Amblyomma americanum (L.)
- Inhibitory mechanism of blood coagulation by the anticoagulant polysaccharide from Coriolus versicolor
- Adsorption of proteins in the processes of interaction of polymers with blood and model solutions
- Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno …
- Extrahepatic expression and regulation of protein C in the mouse
- Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents
- Thrombophilic state in breast cancer
- Dietary fish oil and experimental atherosclerosis
- Enalapril and pregnancy-induced hypertension
- Primary sclerosing cholangitis associated with membranous nephropathy
- Pentasa in lieu of sulfasalazine
- Risks of coronary heart disease in women: current understanding and evolving concepts
- Tamoxifen-Induced Changes in the Plasma Fibrinolytic Factors in Menopausal Women with Breast Cancer.
- Fibrositis and the chronic fatigue syndrome
- COAGULACIÓN FIBRINÓLISIS
- Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability
- Fish oils in rheumatoid arthritis
- Nonbacterial thrombotic endocarditis associated with gold-induced pulmonary disease
- Blood: physical characteristics, formed elements, hemoglobin, and coagulation
- Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis
- Kala-azar and the acquired immunodeficiency syndrome (AIDS)
- Resistance to Activated Protein C and Inherited Thrombosis—Molecular Mechanism, Diagnosis and Clinical Management
- Preventive treatment for tuberculosis in elderly persons
- Guidelines for infection with the human immunodeficiency virus (HIV) and health care workers
- The genetic dynamics of disease
- The pathogenesis, prevention and medical management of peripheral arterial thrombosis
- Vasoactive peptides and the carcinoid syndrome
- Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions
- The early dumping syndrome and propranolol
- New antithrombotics for the intensive care unit setting: GP IIb/IIIa inhibitors, low-molecular-weight heparins, and direct thrombin inhibitors
- Varicella-Zoster Virus Infection
- Perioperative Nutrition
- Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients
- The molecular mechanism of factor Va inactivation by activated protein C
- Immunologic abnormalities in the antiphospholipid syndrome
- Stopping Antibiotics in Neutropenic Patients
- Correction: Intravenous Verapamil and Multifocal Atrial Tachycardia
- Pulse Methotrexate Therapy in Rheumatoid Arthritis
- Asymptomatic Cardiac Ischemia in Diabetic Persons
- Testing for the Human Immunodeficiency Virus (HIV) by Insurance Carriers
- Migratory Erythema and Glucagonoma: Descriptive Nomenclature
- The Doctor-Patient Relationship
- Omissions from A Library for Internists
- Antithrombin III in hematopoietic stem cell transplantation
- Venous Thromboembolism and Advanced Cancer
- Stroke: antithrombin versus antiplatelet therapy
- cated as a mechanism in the development of the disease (1-3). Nonbacterial thrombotic endocarditis can occur in gold-in-duced lung disease and may be a …
- Neurological complications of organ transplantation
- Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis
- Bispectral index (BIS) monitoring of ICU patients on continuous infusion of sedatives and paralytics reduces sedative drug utilization and cost
- Antithrombotic therapy in high-risk pregnancy
- Beverly J. Pennell
- Functional food science and the cardiovascular system
- An investigation of antiphospholipid antibody associated obstetric complications
- Activated protein C resistance in pregnancy
- Anticoagulation and hemostasis in cardiac surgical patients
- Abnormalities of coagulation in experimental nephrotic syndrome
- Plasminogen Activation and Fibrinolysis in the Antiphospholipid Syndrome
- Blood clotting and hemostasis
- Genetics and ischaemic stroke
- Abdominal sepsis in patients 65-onwards after non-scheduled laparotomy
- Case 11-1990: A 38-Year-Old Woman with Fever, Skin Lesions, Thrombocytopenia, and Venous Thromboses
- Antiphospholipid antibodies or not? The role of β2 glycoprotein 1 in autoantibody-mediated pregnancy loss
- Severity evaluation in acute pancreatitis: the role of SOFA score and general severity scores
- Plasma composition in the nephrotic syndrome
- Therapeutic Intervention Scoring System (TISS)-a method for calculating costs in the intensive care unit (ICU) and intermediate care unit (IMCU)
- The fibrinolytic system in neoplasia
- Thrombosis and atherosclerosis
- The clinical relevance of the fluid balance in critically ill patients
- Structure-function relationships in histidine-rich glycoprotein, a putative plasma pH-sensor
- Stress in nursing staff: a comparative analysis between intensive care units and general medicine units
- Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy
- Myocardial Infarction
- Comorbidity risk parameters associated with advanced breast cancer and systemic disease: Management of nonbreast disease
- Tamoxifen induces hypoxia in MCF-7 xenografts
- PROTEIN C AND PROTEIN S: METHODOLOGICAL
- Role of hyperbaric oxygen therapy (HBOT) in recovery of cardiopulmonary function: survival of patients developing ARDS following closed chest trauma (CCT)
- Bacteremia and systemic inflammatory response syndrome (SIRS) in confirmed post-partum endometritis
- Collaborative practice and clinical outcomes in the ICU
- Effects of artificial changes in chest wall compliance on respiratory mechanics and gas exchange in patients with acute lung injury (ALI)
- Bacterial versus viral meningitis: comparison of the old and the new clinical prediction models
- Decreased protein C, protein S and antithrombin III levels are predictive of poor outcome in gram-negative sepsis caused by Burkholderia pseudomallei
- Frequency, mortality and risk factors of candidemia at a tertiary care hospital
- The incidence of ARDS, interim results of the East Anglian ARDS Registry
- Relationship between superimposed pressure and pleural pressure gradient in an experimental model of ARDS
- Laboratory diagnosis of inherited protein S deficiency
- Incidence of cortisol deficiency in patients with traumatic brain injury
- ARDS before and after the start of mechanical ventilation
- Anxiety and depression in family members of ICU patients: ethical considerations regarding decision-making capacity
- Translaryngeal tracheostomy: prospective experience in two Canadian tertiary intensive care units
- Glutamine-enriched parenteral nutrition during postoperative catabolic state
- Serum albumin and mortality risk in critically ill patients
- Hemostasis
- Hypoglycemia masquerading as acute psychosis in young age
- Organization and staffing of intensive care units in Brazil
- Propofol-induced inhibition of intestinal peristalsis involves enteric opioidergic pathways
- Induced moderate hypothermia markedly exacerbates pulmonary hypertension and dysoxia in a neonatal piglet model of elevated pulmonary vascular resistance
- A comparison between oesophageal Doppler and continuous thermodilution for the measurement of cardiac output in critically ill patients
- An audit of unplanned extubations in a medical intensive care unit
- Cytokines and sepsis-just black smoke?
- Immediate complications of central venous cannulation in ICU
- Continuous monitoring of gastric carbon dioxide with optical fibers: European project COMOCADOF, in vitro evaluation
- Renal disease in the elderly
- Are IL-6, IL-10 and PCT plasma concentrations more reliable than APACHE-III or SAPS-II for the individual mortality risk prediction in severe sepsis?
- Evaluation of thoracic fluid contents in patients with acute myocardial infarction
- Delivery of parenteral nutrition byall in one bag'(AIO) versus single bottle system (SBS) in critically ill patients: a prospective randomized trial
- Decrease of red blood cell sialic acid membrane content in septic patients
- Respiratory mechanics studied by multiple regression and the end-inspiratory pause technique during mechanical ventilation
- 13C-stable isotope analyses technique for ICU patients
- Evaluation of a new wireless ECG electrode built in a telemeter in critically ill patients
- Transthoracic cardioversion with damped biphasic waveform shocks
- A prospective trial of surgical resident performed focused abdominal sonography for trauma (FAST): an easy training method
- Evaluation of PCO2 measurements using a gastric air tonometer located in non-mixing solution
- Gastric-arterial pCO2 gradient, but not lactate levels, is related to multiple organ dysfunction assessed by SOFA score in septic patients
- Interleukin-17 stimulates intraperitoneal neutrophil infiltration through the release of the chemokine GROα from peritoneal mesothelial cells
- Epidemiology of cardiac arrhythmias in a medical-cardiologic intensive care unit: single center experience
- Endotoxin-induced pulmonary hyporesponsiveness to inhaled nitric oxide is improved by nitric oxide synthase 2 inhibition
- Hemostasis and coagulation
- Meeting the needs of ICU patient families: a multicentre study
- The change in Bispectral Index with stimulation indicates depth of sedation in intensive care
- Therapeutic activity in elderly medical intensive care patients
- Comparison of pressure-related performance data with data measured by thermodilution in heart failure and sepsis
- Selected biochemical values and organ dysfunction assessment in prediction of difficult to wean patients
- Timing of extubation after esophagectomy
- The predictive value of serial acute physiology score (APS) and simplified acute physiology score II (SAPS II) in post-operative liver transplant patients
- Use of Combitube airway to protect the airway from methylene blue dye
- Secretory phospholipase A2 (sPLA2), procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis and differentiation of septic shock and non-septic shock
- Dexmedetomidine for sedation in the medical ICU
- Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
- Newly developed thrombocytopenia in medical intensive care patients
- The influence of empiric antimicrobial therapy on acquired pulmonary infection in patients with a chest injury on ICU
- Severe mushroom poisoning due to amatoxin in children
- Measurement of gastric emptying in ICU patients with 13C-acetate
- Would the blood volume analyzer-100 (BVA-100) be an alternative to pulmonary artery catheter (PAC) in critically ill patients
- The effect of using a heparin-free flush system for central venous and pulmonary artery catheters on a general medical and surgical intensive care unit
- Antithrombin (AT) improves inflammation induced microcirculatory disturbance in rat mesentery
- G-protein-and phosphodiesterase-dependent regulation of neutrophil migration by antithrombin III involving CXC-receptor 1
- Automatic tube compensation combined with pressure support ventilation-improved work of breathing pattern and less work
- Lipopolysaccharide induced procoagulant activity and cytokine production: influence of antithrombin
- Proportional pressure support in acute lung injury: an observational study
- Systemic and splanchnic hemodynamics, metabolism and PCO2-gap during septic shock induced by live E. coli infusion in dogs
- Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory …
- Triiodothyronine (T3) ameliorates the cytokine storm in rats with sepsis
- Influence of enoximone and dobutamine upon liver perfusion and function in fluid optimized septic patients
- Timing and incidence density of upper gastrointestinal bleeding acquired by critically ill children
- Procalcitonin concentrations in blood after long-distance running
- Effects of a lung recruitment maneuver keeping PEEP before and after L-Pflex on gas exchange in child ARDS patients
- Effects of PEEP and tidal volume on elastances and distribution of volume changes of the different chest wall compartments
- The Effect of Tourniquet Application On Systemic Coagulation
- TISS 76 and TISS 28: outcome discrimination and correlation with length of ICU/hospital stay in 303 consecutive patients of a medical intensive care unit
- Clinical and economic study of the use of somatostatin 14 AA (amino-acids) in the treatment of enterocutaneous and pancreatic fistulas
- Prognostic factors in severe ARDS-patients
- A comparison of pulmonary artery occlusion pressure (PaOP) measurements using pressure controlled ventilation (PCV) versus airway pressure release ventilation …
- Management and outcome of symptomatic hyponatremia in emergency department
- The role of gallium-67 scintigraphy in diagnosing sources of fever in critically ill patients in ICU
- Central neuroaxial blockade improves case-mix adjusted mortality of the critically ill surgical patient
- Comparison of pulmonary arterial and arterial trans-cardiopulmonary thermodilution cardiac output in porcine septic shock
- Decrease in urine output during mesenteric traction syndrome is an early predictor of multiorgan dysfunction
- Treatment of hypophosphataemia in critically ill patients with a two day dosing regimen
- Effects of angiotensin II on the renal excretion of urodilatin in the isolated rat kidney
- A prospective study of the incidence of critical illness polyneuropathy
- Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
- Plasma endothelin-1 and natriuretic peptide levels and antioxidant capacity of heart transplanted patients
- CI/SVRI relationship during different phases of inflammatory response
- Earthquake, rescued victims, crush injury and their follow up
- Is the volume of a pleural effusion predictable using the thickness of the pleural lamella measured by sonography as a reference?
- The lower inflection point of the inspiratory pressure-volume curve overestimates optimal PEEP in surfactant-treated immature lambs
- Differences in phagocytosis by polymorphonuclear leucocytes (PMNs) and monocytes (Mos) in endotoxemia and endotoxin (ET) tolerance
- Inhibition of inducible nitric oxide synthase (iNOS) reduces multi-organ failure (MOF) in the thioacetamide (TAA) rat model
- Partial liquid ventilation combined with two different gas ventilation strategies in acute lung injury in piglets
- The combination of lactate and bicarbonate buffers in continuous venovenous hemodiafiltration and its impact on serum lactate levels and homeostasis
- Muscular mass and subcutaneous fat changes according to duration of ICU hospitalization with corticosteroid and muscle relaxant intake
- The ex vivo production of tumor necrosis factor-α (TNF-α) in men: relationship to cytokine balance during cardiopulmonary bypass
- Severity of illness, critical events, organ failure assessment and ICU outcome
- Relationship between systemic arterial pressure (SAP) and EtCO2 in patients with hemorrhagic shock
- Cardiopulmonary resuscitation with cardiopulmonary bypass after cardiac surgery
- Accidental hypothermia and active rewarming: the metabolic changes observed above and below 32° C
- Influence of prone position on gastric mucosal-arterial PCO2 gradient
- Effective pulmonary capillary pressure during hyperdynamic porcine endotoxemia
- Effects of mercaptoethylguanidine during long-term hyperdynamic porcine endotoxemia
- Effect of continuous hemofiltration (CVVHF) on inflammatory parameters
- A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
- Effect of different tidal volumes and PEEP levels on gas exchange and FRC
- Hospital urinary infection epidemic by Candida famata: reduction of mortality after therapy with fluconazole and identification of the risk factors related to the infection
- Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
- Ileal microcirculation and mucosal acidosis during hyperdynamic porcine endotoxemia
- Experience with brain death and organ donation in a tertiary care hospital in Riyadh, Saudi Arabia
- Protection of spinal cord ischemic injury with the β-agonist Clenbuterol
- In contrast to CD64 expression, CD14 expression is persistently downregulated on polymorphonuclear cells (PMN) but not on monocytes of patients with septic shock
- Effects of epinephrine and norepinephrine on endotoxin-induced tissue factor expression in blood monocytes
- Managing cost in ICU-a report of an experience
- The new way of postoperative pulmonary complications prophylaxis in oesophageal cancer surgery
- Change in the provision of out-of-hours consultant cover improves case-mix adjusted mortality in a district general (university-affiliated) hospital intensive care unit
- Results of transplantation with kidneys from non-heart-beating donors
- Using fraxiparin in patients with gestosis
- Influence of different PEEP levels and tidal volumes on the regional nonaerated tissue: experimental study
- The changes in platelet function in SIRS, sepsis and MODS-a tight connection to the changes in the immune and hemostatic system
- Effects of PEEP above the L-Pflex on gas exchange, hemodynamic and gastric tonometry in ARDS patients
- Relationship between TNFα and IL10 release during cardiac operations and the development of apoptosis
- Pre-admission functional status and outcome in medical intensive care
- An alternative, and more sensitive, approach to detecting differences in outcome in sepsis
- Indocyanine green clearance monitoring during liver transplant for fulminant hepatic failure: preliminary results
- The use of percutaneous tracheostomy in patients with severe acute or chronic liver disease
- Impact of carrier solution on biological insulin availability
- Routine blood gas analysis does not provide information on regional metabolism of the stomach obtained by gastric tonometry in patients with left ventricular failure
- Is redistribution of microcirculatory blood flow within the small intestinal wall the cause of prolonged paralytic ileus in the critically ill?
- Alteration of current perception threshold in severely injured patients
- Effect of iNOS inhibition on exhaled NO and serum nitrate in hyperdynamic porcine endotoxemia
- Evaluation of different CPAP systems in ICU population
- Sepsis increases accumulation of cell-free hemoglobin in intima of submucosal arterioles in rats
- Epinephrine is more effective than other sympathomimetics in correcting cerebral hypoperfusion associated with mesenteric ischemic reperfusion insult
- Gastric mucosal tonometry: should we adjust PiCO2 and CO2-gap to temperature?
- Management of children with severe traumatic brain injury in an adult ICU: evaluation of outcome
- A comparison of the effects of conventional and balloon laryngoscopy on the sagittal dimensions of the space available for the cord at the level of the …
- An experience with surgical admissions to a Paediatric ICU (PICU) in Harare Zimbabwe
- The relationship between data of gastric tonometry by determination of polymorphonuclear leukocytes (PMNs, ie, myeloperoxidase activity) and gut mucosal …
- Mortality and outcome in different subgroups of patients admitted in an ICU
- Non-invasive two-point estimation of arterial PCO2 and alveolar deadspace
- Outcome after major trauma: 12-month follow-up
- Work up to rule out perioperative myocardial infarction: is it overused?
- Detection of perfusion failure during open heart surgery with sublingual PCO2
- Urgent orotracheal intubation induces transient bacteremia in critically ill patients
- Experience of medical examination and health consultation for public exposed to neutrons caused by criticality incident in Japan
- Clonidine concentration-dependently inhibits intestinal peristalsis in vitro
- Diaspirin cross-linked hemoglobin (DCLHb) ensures tissue oxygenation during hemodilution below the critical hematocrit
- Renal blood flow in critically ill cardiac patients: effect of dobutamine on total flow and selective redistribution of the cardiac index
- Endotoxin-induced capillary perfusion failure and leukocyte adhesion is not prevented by the thrombin inhibitor hirudin: an intravital microscopic study
